General Dermatology

Explore the top headlines of 2025, including insights on the latest clinical trials, therapeutic updates, and more.

Innovative approaches in 2025 have enhanced skin health equity by improving global access to dermatology trials, ensuring diverse representation, and community engagement.

Discover groundbreaking FDA dermatology approvals in 2025, featuring innovative therapies for chronic skin conditions and pediatric care advancements.

Dermatology evolves in 2025, focusing on personalized care, safety, and technology integration, while addressing systemic health and patient outcomes.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

John Barbieri, MD, MBA; Ted Rosen, MD; Peter Lio, MD; Shanna Miranti, MPAS, PA-C; and Larissa Schmidt, DPM, share what gifts they would give to the field of dermatology this holiday season.

Hilary Baldwin, MD; Douglas DiRuggiero, DMSc, MHS, PA-C; Diego Ruiz DaSilva, MD; Ken Korber, PA-C; Patrick Burnett, MD, PhD; and Lisa Weiss, PA-C, share what gifts they would give to the field of dermatology this holiday season.

Explore our top performing social media posts of 2025, including insights on the latest clinical trials, FDA approvals, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

In case you missed it, this week we had news on phase 3 data for zasocitinib in psoriasis, wildfire air pollution's impact on AD clinic visits, the FDA's clearance of REX-8756's IND application, and more.

Discover effective treatment strategies for keloids and hypertrophic scars in skin of color, emphasizing personalized approaches and combination therapies.

Energy and protein drinks may exacerbate acne through high sugar and insulin levels, impacting skin health among athletes and students.

What were the top dermatology hits of 2025?

Explore the risks of bypassing dermatologists for DIY skin care and telehealth treatments, highlighting real patient experiences and expert insights.

This review of the latest dermatologic studies includes case studies on allergic contact dermatitis from UV nail polish, the introduction of the visual aesthetics methodology, a review of topical timolol, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the first commercial treatment of Zevaskyn for RDEB, the global prevalence of HS, a new STAT6 degrader for AD, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

John Barbieri, MD, MBA, discusses how deteriorating prior authorization processes are compromising access to essential dermatologic therapies.

Galderma initiates a pivotal study on nemolizumab, targeting Chronic Pruritus of Unknown Origin, aiming to provide relief for this challenging condition.

Explore the emerging concept of PDE4 inhibitor-responsive dermatoses, offering innovative nonsteroidal treatments for chronic inflammatory skin conditions.

Discover how the SkinCARE Questionnaire can measure the emotional impact of everyday skin health, enhancing understanding of skin-related wellbeing in healthy individuals.